Jazz Pharmaceuticals plc
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Total Cash from Operations: $1.36B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Stock Repurchases | $125.0M | 9.2% |
| Other Financing | $371.8M | 27.4% |
| Other | $858.9M | 63.4% |
| Net Cash Flow | $0 | 0.0% |